期刊文献+

雄激素与前列腺疾病 被引量:7

原文传递
导出
摘要 从胎儿期到老年,男性一生之中都依赖雄激素的作用,而前列腺是一个雄激素依赖性器官,体内循环雄激素是前列腺生长发育乃至前列腺增生(BPH)和前列腺癌(PC)发生的基本条件。现就雄激素和前列腺疾病的关系作一阐述。
出处 《中国男科学杂志》 CAS CSCD 2007年第4期65-68,共4页 Chinese Journal of Andrology
  • 相关文献

参考文献30

  • 1Wilson JD,Griffin JE,George FW,et al.The role of gonadal steroids in sexual differentiation.Recent Prog Horm Res 1981;37:1-39
  • 2谷翊群.雄激素制剂在男科中的应用[J].中国男科学杂志,2006,20(5):1-3. 被引量:2
  • 3Walsh PC.The role of estrogen/androgen synergism in the pathogenesis of benign prostatic hyperplasia.J Urol 1988;139(4):826
  • 4隆电熙,莫曾南.性激素在良性前列腺增生发病机制中的作用[J].广西医学,2005,27(9):1394-1396. 被引量:2
  • 5Krieg M,Nass R,Tunn S.Effect of aging on endogenous level of 5alpha-dihydrotestosterone,testosterone,estradiol and estrogne in epithelium and stroma of normal and hyperplastic human prostate.J Clin Endocrinol Metab 1993;77(2):375-381
  • 6Marengo SR,Clung LW.An orthotopic model for the study of growth factors in the ventral prostate of the rat:effects of epidemal growth factor and basic fibroblast growth factor.J Androl 1994;15(4):277-286
  • 7王洛夫,江军,金锡御,靳风烁.雄激素对大鼠前列腺细胞凋亡与生长因子表达的影响[J].临床泌尿外科杂志,2005,20(4):231-233. 被引量:3
  • 8Boget S,Leriche A,Revol A.Basic fibroblast growth factor and keratinocyte growth factor over-expression in benign prostatic hyperplasia.Farmaco 2001;56 (5-7):467-469
  • 9Ibrahim GK.Kerns BJ,MacDonald JA,et al.Diferential immunoreactivity of epidernmal growth factor receptor in benign,dysplastie and malignant prostatic tissues.J Urol 1993;149(1):170-173
  • 10刘岩,蔡文清,贾彬.雄激素对实验性前列腺增生的影响[J].河北医科大学学报,2003,24(2):79-81. 被引量:7

二级参考文献68

  • 1邓方明,顾方六,夏同礼,孔祥田.人良性前列腺增生细胞增殖和凋亡状态的研究[J].中华外科杂志,1996,34(10):620-622. 被引量:30
  • 2Crescioli C, Villari D, Forti G, et al. Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue. Mol-Cell-Endocrinol, 2002, 198: 69-75.
  • 3Barry M, Roehrborn C. Benign prostatic hyperplasia. Clin Evid, 2002, 7: 775-787.
  • 4Rittmaster R S, Manning A P, Wright A S, et al. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5a-reductase inhibition finasteride. Endocrinology, 1995, 136: 741-748.
  • 5Kyprianou N, Tu H, Jaccbs S C. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol, 1996, 27: 668-675.
  • 6Lawson R K. Role of growth factors in benign postatic hyperplasia. Eur Urol, 1997, 32(supple 1): 22-26.
  • 7Boget S, Leriche A, Revol A. Basic fibroblast growth factor and keratinocyte growth factor over-expression in benign hyperplasia. Farmaco, 2001, 56: 467-469.
  • 8Krieg M, Nass R, Tunn S. Effect of aging on endogenous level of 5 α-dihydrotestisterone, testosterone, ostradiol and estrogen in epithelium and stroma of normal and hyperplastic human prostate [J]. J Clin Endocrinol Metab, 1993,77(2) :375 ~ 381.
  • 9Grishkovskaya I,Awakumov GV,Hammond GL, et al. Steroid ligands bind .human sex hormone-binding globulin in specific orientations and produce distinct changes in protein conformation [J].J Biol Chem,2002,277(35):32 086 ~ 32 093.
  • 10Nakhal A, Khan M, Romas N, et al. Estradiol causes the rapid accumulation of cAMP in human prostate [J]. Proc Natl Acad Sci USA, 1994,91 (12):5402~5404.

共引文献23

同被引文献79

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部